Medical Education Library

Practical Treatment Strategies for the Successful Management of Bipolar Disorder


 

A supplement to Clinical Psychiatry News and supported by Lilly.


This supplement has been developed based on the "New Clinical Strategies for the Recognition and Treatment of Bipolar Disorder: Can We Successfully Advance Care?" program that took place on September 14-15, 2007, in San Antonio, Texas. The intent is to provide best practices to clinicians relative to the diagnosis and treatment of bipolar disorder across the life span.


FACULTY
TARGET AUDIENCE
EDUCATIONAL NEEDS
LEARNING OBJECTIVES
ACCREDITATION STATEMENT
CREDIT DESIGNATION


To view the supplement, click the image above. To take the CME Posttest, download and print out the CME Posttest PDF file, and follow the test instructions.

FACULTY

Robert M.A. Hirschfeld, MDCo-Chair
Titus H. Harris Chair,
Harry K. Davis Professor,
Professor and Chair
Department of Psychiatry and Behavioral Sciences
The University of Texas Medical Branch
Galveston, Tex.
Dr Hirschfeld is a consultant and/or has participated in advisory boards for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Jazz Pharmaceuticals, KV Pharmaceutical, Novartis, Organon, Ortho-McNeil, Pfizer, Shire, Solvay Pharmaceuticals, and Wyeth-Ayerst.

Karen Dineen Wagner, MD, PhD
Marie B. Gale
Centennial Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Child and Adolescent Psychiatry
The University of Texas Medical Branch
Galveston, Tex.
Dr Wagner receives grant/research support from the National Institute of Mental Health (NIMH) and is a consultant and/or has participated in advisory boards for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Janssen Pharmaceutica, Novartis, and Otsuka.

S. Nassir Ghaemi, MD, MPH
Associate Professor of Psychiatry and Public Health
Director, Bipolar Disorder Research Program
Emory University
Atlanta, Ga.
Dr Ghaemi receives research grants from, has participated in advisory boards for, and/or is on the speaker

Recommended Reading

CLINICAL UPDATE: Selected Issues in Psychiatry
MDedge Psychiatry
Abuse Potential of Sleeping Agents: Liability Varies Among Agents
MDedge Psychiatry
Physicians Express Frustration With Preauthorization in AMA Survey
MDedge Psychiatry
FDA Wants Lower Acetaminophen Doses in Prescription Pain Drugs
MDedge Psychiatry
Access to Genetic Profiles Fails to Alter Behavior
MDedge Psychiatry
Regressive Form of Autism Has Later Onset, Worse Outcome
MDedge Psychiatry
Habit Reversal Training a Valid Drug Alternative for Tics
MDedge Psychiatry
Lack of Diagnostic Precision Hurts Efforts to Help Children With Outbursts
MDedge Psychiatry
Failure to Thrive Often the First Acknowledgement of Eosinophilic Esophagitis
MDedge Psychiatry
What to look for when evaluating mood swings in children and adolescents
MDedge Psychiatry